Published: July 6, 2026
Author: Dr. med. Simon Feldhaus, President SSAAMP

SSAAMP is a scientific professional society dedicated to integrative thinking and action.
The core principles of our society are:
- Life should not primarily be prolonged, but should be marked by the highest possible quality at every stage. In line with this guiding principle, we place particular emphasis on optimizing quality of life.
- Our work is shaped by recognized medical methods and is based on continuously expanding scientific research.
The International Association of Organ and Stem Cell Therapy Specialists (IAOSS) is an international medical-scientific association founded over 40 years ago in Switzerland, with active participation from Germany and France. IAOSS is committed to advancing organ therapy and cell medicine as complementary medical disciplines, particularly in the context of anti-aging, regenerative medicine, and chronic degenerative diseases.



IAOSS also provides physicians and researchers with a professional platform for exchanging clinical experience, evaluating scientific developments, and discussing therapeutic concepts related to organ extracts, embryonic stem cell applications, and lyophilized preparations from fresh organ cells. The focus is on evidence-based practice, patient safety, and adherence to ethical and regulatory standards.
Cell therapy procedures are currently subject to major restrictions in Germany and Switzerland in particular, and are not approved for use except in a few special indications.
Internationally, however, the situation looks entirely different. In Asia especially, cell therapies are very popular and are widely used therapeutically.
The company ZÉLL-V in Malaysia, with over two decades of experience in anti-aging and regenerative wellness, is a pioneer in the field of cell therapy. Founded by Dato‘ Sharon Foong, the brand helps people activate their body’s natural regenerative potential — going beyond conventional medicine to restore health at the cellular level.



ZÉLL-V is accredited by both IAOSS and the German-French Society for Thymus Therapy (GFSTT), which has an 80-year history.
A medical advisory board made up of international and local physicians and scientists provides strong support for ZÉLL-V.
To scientifically research the mechanisms and outcomes of cellular treatments, IAOSS regularly organizes international symposia.
In 2026, the symposium was held under the title:
Beyond Chronological Age: The Role of Cellular Therapy in Life Extension Medicine
This ties in directly with the core principles of anti-aging medicine.
As President of SSAAMP, I had the honor of being invited by IAOSS as a keynote speaker at the symposium in Kuala Lumpur in April, and I accepted this invitation.
The talk I gave was titled:
„Cellular Therapy in Life Extension and Integrative Medicine.“
The symposium was very well attended, with physicians from various Asian countries including the Philippines, China, Malaysia, and many more.
Professor Dr. Nor Shahidah Khairullah from ZÉLL-V presented her experience under the title „Xenogeneic Cellular Therapy in Regenerative Medicine.“ Further talks covered „Cellular Therapy for Post-Covid Health Improvement“ and „The Roles of Cellular Aging in the Scientific Development of Life Extension Treatment Strategies.“
The symposium was a great success, showcasing impressive case reports on the integrative use of stem cells in treating highly complex diseases as well as in preventive medicine.



Cell-based treatments should definitely continue to be researched scientifically, and possible therapeutic options should be discussed and made available for further patients and indications through the exchange of experience with physicians in the Asian region.
The ban on these treatments in both Switzerland and Germany appears, from a scientific standpoint, hard to understand, as it prevents professional scientific discussion and research — which does not align with the fundamental principles of medicine.
The collaboration between SSAAMP and IAOSS has proven to be entirely positive and is to be continued and expanded in the future. Planned activities include scientific collaboration as well as physician exchange for continuing education.
We were also able to gain new members from Malaysia, allowing SSAAMP to represent itself internationally and significantly enhance its reputation.
Further joint symposia between the professional societies are planned for the future.



Dr. med. Simon Feldhaus
President SSAAMP
www.ssaamp.ch










